Skip to main content

Advertisement

Log in

Docetaxel neuropathy: a distal axonopathy

  • Case report
  • Published:
Acta Neuropathologica Aims and scope Submit manuscript

Abstract

Docetaxel has been implicated as a causative agent in peripheral neuropathy, but pathological changes in peripheral nerve have not been described. During docetaxel treatment a 54-year-old man developed a sensorimotor polyneuropathy when the overall docetaxel dosage was 540 mg/m2. Neurophysiological investigation revealed a sensorimotor axonal neuropathy. Fascicular sural nerve biopsy showed an axonal neuropathy with a preferentially loss of large myelinated fibers. There was evidence of considerable fiber regeneration. Sensory and motor symptoms progressively improved after docetaxel withdrawal.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Additional information

Received: 21 January 1999 / Revised, accepted: 25 March 1999

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fazio, R., Quattrini, A., Bolognesi, A. et al. Docetaxel neuropathy: a distal axonopathy. Acta Neuropathol 98, 651–653 (1999). https://doi.org/10.1007/s004010051132

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s004010051132

Navigation